PROTEIN INHIBITORS OF CALCIUM PHOSPHATE PRECIPITATION
磷酸钙沉淀的蛋白质抑制剂
基本信息
- 批准号:3219891
- 负责人:
- 金额:$ 14.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1982
- 资助国家:美国
- 起止时间:1982-02-01 至 1990-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Human saliva is supersaturated with respect to the calcium
phosphate salts which form dental enamel, a condition which would
normally generate unwanted and potentially harmful precipitation
of calcium phosphate salts in the salivary glands and on the teeth.
These, undesirable side effects are prevented by 2 salivary
phosphoprotein, statherin and the acidic proline-rich proteins
(PRP), which are potent inhibitors of calcium phosphate
precipitation. Because of their activities, saliva provides a
prospective, reparative but stable environment which is important
for maintaining the health of the teeth. Our objectives are to
gain a sound understanding of these protective and reparative
functions, to relate them to oral health and disease, and to
achieve a level of knowledge which will help to ensure that these
natural oral defense mechanisms fully express themselves in the
mouth. Previous studies by the applicant and co-investigators led
to the identification of statherin and the PRP's as inhibitors of
calcium phosphate precipitation, made a major contribution to the
determination of their structures, and made substantial advances
towards establishing the molecular mechanisms by which these
unusual macromolecule act. It is now proposed to advance
understanding of these functions and mechanisms of action of these
molecules in the following ways: 1) by synthesizing phosphoserine-
containing peptide analogs of statherin and the PRP's for structure
studies b) by investigating mechanisms of post-translational
phosphorylation of statherin and the PRP's by using serine-
containing peptide analogs specifically synthesized for this
purpose, 3) by studying analogs of statherin and the PRP's from
nonhuman mammals to gain further insights into structure-function
relationships and evolutionary aspects of these molecules, and 4)
by studying specific aspects of the behavior and fate of statherin
and the PRP's in the oral cavity, an important site at which they
act but where they are subject to degradation by oral microflora.
The work will be advanced by use of modern gas-phase
microsequencing methods and solid phase peptide synthesis
techniques. From this work will come advances in understanding of
an important tooth-protective system and new knowledge of the
modulation of the chemistry of calcium phosphates by specific and
unusual phosphoprotein.
人类唾液中的钙是过饱和的
形成牙釉质的磷酸盐,
通常会产生不需要的和潜在有害的降水
唾液腺和牙齿上的磷酸钙盐。
这些不良的副作用是防止2唾液
磷蛋白,statherin和酸性脯氨酸丰富的蛋白质
(PRP),这是磷酸钙的有效抑制剂
降水 由于它们的活动,唾液提供了一个
具有前瞻性、修复性但稳定的环境,
保持牙齿的健康。 我们的目标为
充分了解这些保护性和修复性
功能,将它们与口腔健康和疾病联系起来,
达到一定的知识水平,这将有助于确保这些
自然的口头防御机制充分表达自己在
嘴里 申请人和合作研究者之前的研究
用于鉴定作为抑制剂的雄甾苷和PRP,
磷酸钙沉淀,作出了重大贡献,
确定其结构,并取得了重大进展
以建立分子机制,
不寻常的大分子行为。 现拟推进
了解这些功能和作用机制,
通过以下方式合成分子:1)通过合成磷酸丝氨酸-
含有statherin的肽类似物和用于结构的PRP
研究B)通过研究翻译后的机制,
使用丝氨酸磷酸化Statherin和PRP
含有专门为此合成的肽类似物
目的,3)通过研究Statherin的类似物和来自
非人类哺乳动物获得进一步的了解结构功能
这些分子的关系和进化方面,以及4)
通过研究斯塔德林的行为和命运的特定方面,
而富血小板血浆位于口腔中,这是它们发挥作用的重要部位
但它们会受到口腔微生物菌群的降解。
现代气相色谱技术的应用将进一步推进这一工作
微测序方法和固相肽合成
技术. 从这项工作中,我们将进一步了解
一个重要的牙齿保护系统和新的知识
通过特定的和
不寻常的磷蛋白
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID H SCHLESINGER其他文献
DAVID H SCHLESINGER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID H SCHLESINGER', 18)}}的其他基金
STRUCTURAL STUDIES ON THE PLASMODIUM SURFACE PROTEINS
疟原虫表面蛋白的结构研究
- 批准号:
3133555 - 财政年份:1985
- 资助金额:
$ 14.68万 - 项目类别:
STRUCTURAL STUDIES ON THE PLASMODIUM SURFACE PROTEINS
疟原虫表面蛋白的结构研究
- 批准号:
3133554 - 财政年份:1985
- 资助金额:
$ 14.68万 - 项目类别:
STRUCTURAL STUDIES ON THE PLASMODIUM SURFACE PROTEINS
疟原虫表面蛋白的结构研究
- 批准号:
3133551 - 财政年份:1985
- 资助金额:
$ 14.68万 - 项目类别:
PROTEIN INHIBITORS OF CALCIUM PHOSPHATE PRECIPITATION
磷酸钙沉淀的蛋白质抑制剂
- 批准号:
3219889 - 财政年份:1982
- 资助金额:
$ 14.68万 - 项目类别:
PROTEIN INHIBITORS OF CALCIUM PHOSPHATE PRECIPITATION
磷酸钙沉淀的蛋白质抑制剂
- 批准号:
2129326 - 财政年份:1982
- 资助金额:
$ 14.68万 - 项目类别:
PROTEIN INHIBITORS OF CALCIUM PHOSPHATE PRECIPITATION
磷酸钙沉淀的蛋白质抑制剂
- 批准号:
3219892 - 财政年份:1982
- 资助金额:
$ 14.68万 - 项目类别:
PROTEIN INHIBITORS OF CALCIUM PHOSPHATE PRECIPITATION
磷酸钙沉淀的蛋白质抑制剂
- 批准号:
3219894 - 财政年份:1982
- 资助金额:
$ 14.68万 - 项目类别:
PROTEIN INHIBITORS OF CALCIUM PHOSPHATE PRECIPITATION
磷酸钙沉淀的蛋白质抑制剂
- 批准号:
3219893 - 财政年份:1982
- 资助金额:
$ 14.68万 - 项目类别:
PROTEIN INHIBITORS OF CALCIUM PHOSPHATE PRECIPITATION
磷酸钙沉淀的蛋白质抑制剂
- 批准号:
3219895 - 财政年份:1982
- 资助金额:
$ 14.68万 - 项目类别:
PROTEIN INHIBITORS OF CALCIUM PHOSPHATE PRECIPITATION
磷酸钙沉淀的蛋白质抑制剂
- 批准号:
3219890 - 财政年份:1982
- 资助金额:
$ 14.68万 - 项目类别:
相似海外基金
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
- 批准号:
DP240103141 - 财政年份:2024
- 资助金额:
$ 14.68万 - 项目类别:
Discovery Projects
Structural classification of NHEJ pathways; unravelling the role of Ku-binding proteins
NHEJ通路的结构分类;
- 批准号:
MR/X00029X/1 - 财政年份:2023
- 资助金额:
$ 14.68万 - 项目类别:
Research Grant
BRC-BIO: Evolutionary Patterns of Ice-Binding Proteins in North Pacific Intertidal Invertebrates
BRC-BIO:北太平洋潮间带无脊椎动物冰结合蛋白的进化模式
- 批准号:
2312378 - 财政年份:2023
- 资助金额:
$ 14.68万 - 项目类别:
Standard Grant
Exploring the roles and functions of sex steroid hormone receptor-associated RNA binding proteins in the development of geriatric diseases.
探索性类固醇激素受体相关 RNA 结合蛋白在老年疾病发展中的作用和功能。
- 批准号:
23K06408 - 财政年份:2023
- 资助金额:
$ 14.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
UV Plasmon-Enhanced Chiroptical Spectroscopy of Membrane-Binding Proteins
膜结合蛋白的紫外等离子增强手性光谱
- 批准号:
10680969 - 财政年份:2023
- 资助金额:
$ 14.68万 - 项目类别:
Investigating physiologic and pathophysiologic connections between the Parkinson's disease protein alpha-synuclein and RNA binding proteins
研究帕金森病蛋白 α-突触核蛋白和 RNA 结合蛋白之间的生理和病理生理联系
- 批准号:
10744556 - 财政年份:2023
- 资助金额:
$ 14.68万 - 项目类别:
Structural and computational analysis of immune-related RNA-binding proteins
免疫相关 RNA 结合蛋白的结构和计算分析
- 批准号:
23K06597 - 财政年份:2023
- 资助金额:
$ 14.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Characterization of carbohydrate-binding proteins and their applications
碳水化合物结合蛋白的表征及其应用
- 批准号:
23K05034 - 财政年份:2023
- 资助金额:
$ 14.68万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A machine learning approach to identify carbon dioxide-binding proteins for sustainability and health
一种机器学习方法来识别二氧化碳结合蛋白以实现可持续发展和健康
- 批准号:
2838427 - 财政年份:2023
- 资助金额:
$ 14.68万 - 项目类别:
Studentship
The role of RNA binding proteins in heart development and congenital heart defects
RNA结合蛋白在心脏发育和先天性心脏缺陷中的作用
- 批准号:
10827567 - 财政年份:2023
- 资助金额:
$ 14.68万 - 项目类别: